1,2-Dibromoethane causes rat hepatic DNA damage at low doses

Area of Science:

• Toxicology
• Molecular Biology
• Biochemistry

Background:

• 1,2-dibromoethane (EDB) is a known carcinogen with documented toxic effects.
• Previous studies have indicated EDB's potential to induce DNA damage, but dose-response relationships require further clarification.

Purpose of the Study:

• To investigate the dose-dependent induction of DNA damage by EDB in various organs of adult female rats.
• To compare the dose levels of EDB required for DNA damage versus other biochemical effects and liver toxicity.

Main Methods:

• Adult female rats received two oral doses of EDB (10-300 mumol/kg).
• Hepatic DNA damage was assessed using the alkaline elution technique.
• Biochemical markers including ornithine decarboxylase, cytochrome P-450, glutathione, and serum alanine aminotransferase were measured.
• DNA damage was also evaluated in blood, bone marrow, kidney, spleen, and thymus.

Main Results:

• Liver exhibited the most significant DNA damage among the six organs studied.
• EDB doses at or above 10 mumol/kg induced detectable DNA damage.
• Substantial DNA damage occurred at EDB doses 40-fold lower than previously reported.
• Higher EDB doses (≥300 mumol/kg) were necessary to elicit other biochemical effects like increased ornithine decarboxylase activity.

Conclusions:

• EDB is a potent genotoxic agent, causing significant DNA damage at doses considerably lower than those inducing other biochemical alterations or overt liver toxicity.
• The alkaline elution technique is sensitive for detecting EDB-induced DNA damage at low exposure levels.
• These findings highlight the critical need for stringent regulation of EDB exposure due to its potent genotoxicity.